Rays of Belief IPO Review 2026: Should You Apply or Avoid? | Price, GMP, Financials & Risks

Описание: Rays of Belief IPO Review 2026: Should You Apply or Avoid? | Price, GMP, Financials & Risks #shorts

Rays of Belief is the parent company of Mom's Belief, a chain of child-development and early-intervention therapy centres that provide occupational, speech, behavioural and other therapies for children with developmental delays and special needs. The company is launching a ₹125 crore mainboard IPO, comprising an entirely fresh issue of approximately 52.30 lakh shares (face value ₹10), with no OFS component.

In your 60-second short, you can cover:

IPO basics:
Price band: ₹227–₹239 per share.

Lot size: 62 shares; minimum retail investment ₹14,818, maximum ₹1,92,634 (13 lots).

IPO dates: 1–3 September 2026; allotment on 4 September, refunds/demat on 7 September and listing on 8 September 2026.

Issue structure: 100% fresh issue of ₹125 crore.

Proposed listing: NSE and BSE.

Business strengths:
Rays of Belief operates a scaling chain of child-development therapy centres under the Mom's Belief brand, addressing a growing need for early-intervention and special-needs care. The IPO proceeds are earmarked to fund expansion into 319 therapy centres, a clear growth plan.

The company may benefit from rising awareness of developmental disorders, growing demand for therapy services and the expansion of specialised paediatric care in India.

Financial performance:
Rays of Belief posted strong top-line growth. Revenue from operations jumped from ₹36.42 crore in FY25 to ₹81.66 crore in FY26 (up ~125%).

However, PAT declined from ₹5.88 crore in FY25 to ₹4.96 crore in FY26, showing that rapid expansion is compressing profitability. FY24 PAT was just ₹0.85 crore, so earnings are still small relative to the revenue base.

Valuation and GMP:
At the upper price band of ₹239, the IPO values the company at a premium to its current earnings, given the modest profit base. Investors should compare the valuation with listed healthcare and education-services peers.

The latest GMP is reported around ₹6–₹29 per share, implying a possible listing gain of roughly 2.5%–12%, if the premium remains stable. GMP is unofficial and can change quickly before listing.

Key risks:
Profitability is declining despite strong revenue growth, signalling execution and margin pressure.

Centres operate on leased premises with fit-out costs that may not be recoverable if a lease is not renewed.

Regional concentration — about 15.36% of FY26 revenue came from UP, Karnataka and Delhi, and 17.58% from Tier-2 cities.

About 25.56% of FY26 revenue came from the export of support services to related party Carving Futures Pte, creating related-party dependence.

Expansion into 319 centres carries significant execution and funding risk.

GMP is unofficial and should not be the only basis for applying.

Verdict line for the short:
"Rays of Belief offers a strong growth story with revenue up 125% and a clear 319-centre expansion plan, but falling profits, related-party dependence and heavy execution risk make it a high-risk, selective-apply IPO—not for conservative investors."


rays of belief ipo review 2026, rays of belief ipo review, rays of belief ipo gmp today, rays of belief ipo price band 227 239, rays of belief ipo dates 1 to 3 september 2026, rays of belief ipo lot size 62 shares, rays of belief ipo listing date 8 september 2026, rays of belief ipo financials, rays of belief ipo valuation, rays of belief ipo apply or avoid, rays of belief gmp today, moms belief ipo, child development therapy centres ipo, early intervention therapy company, paediatric therapy ipo india, rays of belief revenue and profit, healthcare services ipo 2026, special needs therapy company, mainboard ipo 2026, new ipo 2026, listing gain ipo 2026, ipo analysis 2026, indian stock market ipo 2026, long term view on rays of belief, healthcare stocks india, child care services stocks, stock market shorts, ipo review shorts, IPO investing India, apply or avoid ipo, finance shorts, therapy services stocks, education and healthcare ipo, high risk ipo, growth stock ipo